GEN Exclusives

More »

GEN News Highlights

More »
Sep 14, 2010

Sigma Life Science to Provide Oligonucleotides to Research Councils UK

  • Sigma Life Science signed a three-year contract with Research Councils UK (RCUK) Shared Services Centre to be a prefered supplier for synthetic oligonucleotides. With more than 20 years of experience in oligonucleotide synthesis, the company offers a broad, commercially available range of high-quality oligonucleotide modifications, purifications, synthesis scales, and qPCR probes. It has a U.K. production facility in Haverhill, near Cambridge.

    “Sigma Life Science has been a preferred oligonucleotide supplier to the Medical Research Council (one of the U.K.’s seven Research Councils) for over four years,” notes Michael Harris, managing director of Europe, Middle East, and Africa regions for Sigma-Aldrich. “This new agreement is expected to enable additional RCUK researchers to access Sigma’s products as well as allow Sigma Life Science to consolidate its relationship with RCUK.”

    Sigma Life Science provides a range of other molecular biology reagents including nucleic acid amplification and purification reagents, RNAi products like shRNAs, siRNAs, and ZFN technology, as well as more than 38,000 antibodies.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?